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Abstract
Purpose—Peripheral neuropathy (PN) is highly prevalent condition with serious sequelae. 
However, many studies of the condition have been restricted to populations with diabetes, limiting 
evidence of potential contributing risk factors including salient psychosocial risk factors such as 
discrimination.
Methods—The longitudinal Study of Women’s Health Across the Nation was used to assess the 
relationship between perceived discrimination and prevalent peripheral neuropathy in 1,718 
racially/ethnically diverse midlife women. We used multivariable logistic regression to determine 
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the association between perceived discrimination (Detroit Area Study Everyday Discrimination 
Scale) and PN (symptom questionnaire and monofilament testing) and conducted a formal 
assessment of the mediating effects of body mass index (BMI).
Results—The overall prevalence of PN was 26.1% in the total sample and 40.9% among women 
with diabetes. Women who reported perceived discrimination had 29% higher odds of PN as 
compared to women who did not report perceived discrimination (95% confidence interval (CI): 
1.01, 1.66). Approximately 30% of the total effect of discrimination on PN was mediated 
indirectly by BMI.
Conclusions—More research is needed to determine the contributing factors to non-diabetic 
PN. Additionally findings re-affirm the impact of financial strain, BMI and diabetes as significant 
correlates of PN and highlight discrimination as an important risk factor.
Keywords
peripheral neuropathy; discrimination; diabetes; SWAN; midlife; diabetes; women
Peripheral neuropathy (PN) is characterized by damage to various classes of peripheral 
nerves and is a common comorbidity associated with diabetes. The sensory, autonomic and 
motor nerve damage that define the condition can cause a multitude of symptoms and signs 
including pain, numbness, loss of sensation, muscle atrophy, loss of balance, incontinence, 
and blood pressure irregularities (1). In the United States (US), approximately 20 million 
people are estimated to have PN (1). According to the American Diabetes Association, about 
25% of people over 60 years of age have diabetes (2) and half of these older adults with 
diabetes are estimated to have PN (1,3).
While PN is more prevalent in populations with diabetes, research suggests that the burden 
of PN is high even among populations without diabetes. One study of a nationally 
representative United States sample estimated the prevalence of PN among individuals age 
40+ years and without diabetes be 13% (4). Within the Study of Women’s Health Across the 
Nation (SWAN) Michigan site, a subset of non-Hispanic white and African American 
participants from the larger SWAN cohort, the prevalence of PN among women with an 
average age of 57.6 years was 27.8% in the total sample and 26.2% among those without 
diabetes (5). While the pathophysiology of nerve damage is due, in part, to chronic 
hyperglycemia associated with diabetes, little is known about the pathogenesis of or risk 
factors for peripheral nerve dysfunction among individuals without diabetes. Emerging 
evidence suggests that mechanisms associated with obesity and the aging process may be 
detrimental to peripheral nerves (6–8).
Evidence is conflicting about the prevalence of PN in different racial/ethnic groups. Some 
studies have found minimal differences by racial/ethnic groups, with a lower prevalence 
among African Americans and Hispanics compared to Whites, while other studies have 
found no racial/ethnic difference in PN prevalence (9–11). Diabetes is intricately related to 
the diagnosis and understanding of PN, and the distribution of diabetes is not uniform across 
racial/ethnic groups in the United States. The prevalence of diagnosed and undiagnosed 
diabetes among African Americans is estimated to be nearly twice that in Whites, and 
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African Americans die of diabetes at a rate 1.3 times higher than Whites (12,13). A higher 
prevalence of undiagnosed diabetes among African-Americans (12,13) may be also 
contributing to the lower detected prevalence of diabetes related sequelae such as peripheral 
neuropathy.
Discrimination has been noted as a salient psychosocial factor linked to several chronic 
health conditions including hypertension, coronary artery disease, and insomnia among all 
racial/ethnic groups, with many studies reporting a higher prevalence of perceived 
discrimination among racial/ethnic minorities compared to Whites (14–20). Additionally, 
there has been conflicting evidence of moderation of the effect of discrimination among 
racial/ethnic minorities compared to Whites (16,17,19) particularly for conditions closely 
linked to diabetes such as metabolic syndrome (17,19). Perceived discrimination, including 
internalized racism, is also associated with high-risk body size (21–23). A commonly 
hypothesized model for the association between discrimination and chronic disease is that 
discrimination causes a chronic stress response that leads-through various biological 
mechanisms including allostatic load and inflammation - to chronic health conditions, such 
as diabetes (17,24,25). This work suggests that studies evaluating chronic diseases such as 
diabetes and cardiovascular disease should account for the potential role of discrimination 
and obesity. However, the relationship between discrimination, obesity, and PN has not been 
investigated.
This paper examined whether midlife perceived discrimination is associated prospectively 
with the prevalence of PN in the multi-ethnic Study of Women’s Health Across the Nation 
(SWAN). Additionally, given the complex relationship between race, socio-economic status, 
diabetes and PN we investigated whether the relationship between discrimination and PN 
varied by diabetes status. Lastly, as perceived discrimination is associated with body mass 
index (BMI) and central obesity (21–23), we also assessed whether this association was 
mediated by BMI.
METHODS
The Study of Women’s Health Across the Nation is a multi-ethnic longitudinal study of 
midlife women from seven sites in the United States. Each of the clinical sites selected 
White women and women of one designated racial/ethnic minority group to participate. 
African-American women were recruited in Boston, MA, Chicago, IL, Detroit-area, MI, and 
Pittsburgh, PA; Chinese women in Oakland, CA; Hispanic women in Newark, NJ; and 
Japanese women in Los Angeles, CA. Women were eligible for the baseline assessment in 
1996 if they were between 42 and 52 years of age, had an intact uterus and at least one 
ovary, had no reported current hormone use, had at least one menstrual period in the past 3 
months, and self-identified as one of the site’s designated racial/ethnic groups. There have 
been an additional 15 approximately annual visits following baseline. Visits include both 
self-reported questionnaires and clinic visits. Further detailed information about SWAN 
study procedures and methods have been published elsewhere (26). Of the initial 3,302 
enrolled women, 2,091 (63%) participated in study visit 15 (2016). The women who 
participated in visit 15 but were missing data for neuropathy status, diabetes status, body 
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mass index, or baseline perceived discrimination were excluded from the present analysis, 
leaving 1,718 women (82%) in the analytic sample.
Perceived discrimination was assessed during the baseline visit using the Detroit Area Study 
Everyday Discrimination Scale (27,28); responses on this scale have been shown to be 
consistent over time among women in the SWAN cohort (19). This scale measures ten 
experiences involving discrimination over the past 12 months such as being treated with less 
respect or courtesy than other people, receiving poorer service than others, and being 
ignored. Each question was assessed using a response scale of never, rarely, sometimes, and 
often. Responses were summed and averaged across the 10 questions to yield final scores 
between 1 (low perceived discrimination) and 4 (high perceived discrimination) (29). The 
questions above were not specific to reasons for discrimination, however there was a follow 
up question that asked participants to attribute their experience of discrimination to one 
major reason (race/ethnicity, sex, etc.). Previous studies in SWAN show that African-
American and Chinese women report slightly higher levels of perceived discrimination than 
other racial/ethnic groups (29).
PN was assessed during visit 15 using both a symptom questionnaire and monofilament 
testing. The Michigan Neuropathy Screening Instrument (MNSI) symptom questionnaire 
acquired information about 15 neuropathy symptoms including burning pain, sensitivity, 
prickling, lack of hot/cold differentiation, severe dryness of the foot, numbness, open sores, 
and amputations (30). Participants who identified having 4 or more of these 15 symptoms 
were categorized as having PN from the screening instrument. This questionnaire and cut-
point have been previously validated with clinical diagnoses of PN (31).
The monofilament test was first administered using a 10-gram filament placed on the big toe 
for less than one second for four repetitions. If the participant correctly identified all 4 
repetitions, this procedure was repeated with a 1.4-gram monofilament in order to measure 
more minute levels of insensitivity. Participants who responded correctly to 2 or fewer of 4 
attempts on either the 10-gram or the 1.4-gram test were classified as having PN from the 
monofilament test. For this analysis, women who screened positive on either the 
questionnaire or the monofilament test were classified as having PN in order to capture a 
broad range of neuropathy symptoms and sub-types.
Diabetes status was ascertained using a combined measure that included self-reported use of 
a diabetes medication including insulin, self-reported doctor-diagnosed diabetes, or a fasting 
glucose ≥ to 126 mg/dL at any follow-up visit. Race/ethnicity was self-identified at baseline 
as African-American, Chinese, Hispanic, Japanese, or White. To ensure temporality between 
perceived discrimination and body mass index (BMI), and because BMI has been 
hypothesized to change through the menopausal transition independently of discrimination 
(32–34), BMI was ascertained concurrently (visit 15) with PN when most women in the 
sample were post-menopausal. BMI was calculated as weight in kilograms divided by 
measured height in meters squared. Smoking status was based on self-report at visit 15 of 
smoking regularly since the last study visit. Financial strain at baseline was assessed by self-
report of how hard it is for the respondent to pay for basics.
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Frequencies, means, and 95% confidence intervals (CI) were calculated to define the 
characteristics of the eligible study population. Chi-square tests and t-tests were used to test 
for significant differences in characteristics between women with and without diabetes and 
with and without PN. Logistic regression adjusted for race/ethnicity, financial strain, 
smoking status, and diabetes was performed to investigate the relationship between 
perceived discrimination reported at baseline and PN at visit 15. Additionally, an interaction 
between race/ethnicity and perceived discrimination was tested. BMI was added to the 
models in order to assess whether BMI could potentially mediate the relationship between 
perceived discrimination and PN. A formal mediation analysis to determine whether BMI 
mediated the effect of discrimination on PN was conducted using the STATA package 
Paramed (StataCorp LP, College Station, Texas), which decomposes the total effect of 
discrimination on PN into direct (effect of discrimination alone), indirect (effect of 
discrimination via BMI) and interactive (discrimination and BMI interaction) effects using 
the methods outlined by Vanderweele, 2013 (35–37). Because diabetes is a strong risk factor 
for PN we also tested for interactions between discrimination and diabetes status in all 
models.
RESULTS
The median baseline age of participants was 46.2 years and the median age at visit 15 was 
65.4 years. Approximately one-third of the sample (33.9%) reported financial strain at 
baseline (Table 1). The average discrimination score was 1.7 (standard deviation (SD) = 0.5) 
with a range of 1.0 to 3.6, 8.91% of the sample reported no instances of discrimination at 
baseline. The prevalence of diabetes was 3.6% at baseline and 18.6% by visit 15. At visit 15, 
68.6% of the sample was overweight or obese, and the average BMI was 29.2 kg/m2 (SD = 
7.1).
By visit 15, 26.1% of women had PN. The prevalence of PN was higher among women with 
diabetes (40.9%) compared to women without diabetes (22.8%). Of those with PN, 62.8% 
were classified as having the condition based on the MNSI questionnaire, 51.7% based on 
the monofilament test and 14.5% based on both measures (Table 2).
In unadjusted analyses, financial strain and higher perceived discrimination at baseline as 
well as higher BMI, smoking, and diabetes at visit 15 were positively associated with PN at 
visit 15 (Table 3). Each unit increase in level of perceived discrimination was associated 
with 43% higher odds of PN (odds ratio (OR) = 1.43, 95% CI: 1.14, 1.79). Japanese women 
had 72% lower odds of PN compared to white women (OR = 0.28, 95% CI: 0.16, 0.48), but 
there were no significant differences in the odds between African-American, Chinese, or 
Hispanic women and White women.
After adjustment for race/ethnicity, financial strain, current smoking, and diabetes, perceived 
discrimination remained positively associated with PN (Model 1). Each unit increase in 
perceived discrimination was associated with 29% higher odds of PN (OR = 1.29, 95% CI: 
1.01, 1.66). Next we further adjusted for BMI (Model 2). Doing so attenuated the estimate 
for perceived discrimination, and it was no longer significantly associated with PN (OR = 
1.21, 95% CI: 0.94, 1.56). In the fully adjusted model, Japanese women had 67% lower odds 
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of PN as compared to White women (OR=0.33, 95% CI: 0.19, 0.58), and financial strain, 
smoking status, diabetes and BMI were positively associated with PN. There was no 
significant interaction between discrimination and racial/ethnic group or diabetes.
Sensitivity analysis indicated no significant interactive effect between discrimination and 
BMI in association with PN (likelihood ratio chi-squared = 0.29, two-sided P-value = 0.59), 
therefore controlled (non-interactive) direct and indirect effects are presented in the 
mediation analysis (Table 4). The total effect of discrimination on PN is estimated to be 
28.3% (95% CI: 17.1, 36.5%) mediated by BMI (indirect effect); the direct effect of 
discrimination is non-significant and is slightly higher (OR = 1.21, 95% CI: 0.94, 1.56) than 
the indirect effect of discrimination via BMI (OR = 1.07, 95% CI: 1.03, 1.12).
DISCUSSION
This is the largest known study of PN in women without and with diabetes. Among women 
aged 60 to 73 years old, the prevalence of neuropathy was 22.8% in women without diabetes 
and 40.9% in women with diabetes. Perceived discrimination in midlife was a predictor of 
having PN 20 years later, and this association was mediated significantly by BMI. We also 
found that financial strain, higher BMI, current smoking, and diabetes were all associated 
with an increased odds of PN, confirming prior observations (20–23).
This is the first analysis of the association of discrimination and PN, and we found that each 
increasing level of perceived discrimination in midlife was associated with 43% higher odds 
of PN. Discrimination has been found to be a strong indicator for risk of many serious health 
conditions, including diabetes, obesity and hypertension (10,24–27). Discrimination, along 
with other types of stressors, increases allostatic load, or the overstimulated or abnormal 
neurological, immunological, and inflammatory physiological responses induced by chronic 
stressors (18,19,45–56). Discrimination and other chronic stressors are associated with 
heightened responsiveness of the cardiovascular system including increased blood pressure 
reactivity (57,58), red blood cell oxidative stress (59) and increased inflammation (54). 
Cardiometabolic risk factors including diabetes are associated with PN among individuals 
with and without diabetes (60) and more recently, diabetic PN was associated with 
endothelial dysfunction (61). Thus, chronic stressors such as discrimination may be 
associated with PN through the dysregulation of cardiovascular and metabolic function and 
pro-inflammatory responses that lead to damage of the peripheral nerves (16, 17). 
Furthermore, previous work has found an association between discrimination and chronic 
pain (62,63), potentially through psychological distress (62). Because the symptoms of PN, 
particularly in the early stages, are characterized by chronic pain it could be that 
discrimination is at play through the same neurological pathways as chronic pain among 
both diabetic and non-diabetic PN cases.
While perceived discrimination was a strong predictor for PN in the unadjusted model, this 
association was attenuated to non-significance when adjusted for BMI – BMI was the most 
highly significant predicator of PN in the present analysis. Formal mediation results suggest 
that the association between discrimination and PN is approximately 28.3% (95% CI: 17.1‒
36.5%) mediated by BMI. In SWAN and elsewhere, discrimination has been shown to be an 
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independent predictor of BMI (64,65), and discrimination has been found to be a predictor 
of inflammation with significant moderation by BMI (66). Furthermore, increased body 
mass index has been shown to contribute to decreased nerve conduction among individuals 
without diabetes who do not yet have any symptoms of PN (39). Even when no neuropathy 
symptoms were reported by those participants, they had significantly lower thermal and pain 
thresholds. This lends support to the mediation results and suggests that the underlying 
mechanism for discrimination’s effect on risk of PN may be related to the physiological 
effects of obesity and inflammation.
Other factors such as low socioeconomic status and smoking were found to be associated 
with prevalent PN. Women with lower socioeconomic status have been shown to have higher 
allostatic load stress markers, which according to the proposed biological mechanism above, 
could account for some of the increased odds of developing PN for women reporting 
financial strain (17,68). People of lower socioeconomic status also have poorer nutrition, 
exercise less, have potentially more exposure to environmental toxins, and have less access 
to health care than women of higher socioeconomic status (69–71). Even women who seek 
care for PN symptoms may be less likely to be properly tested and diagnosed based on their 
socioeconomic status (72). All of these factors may lead to poorer management and greater 
exacerbations of diseases such as PN among women of lower socioeconomic status. 
Furthermore, a recent meta-analysis found that smoking was significantly associated with an 
increased odds of diabetic PN (40). Our results are consistent with these findings. Smoking 
is hypothesized to contribute to neuropathies by constricting the blood vessels that supply 
nerves with blood and nutrients (73).
The observed prevalence of PN in our present analysis is higher than reported in previous 
studies among women with and without diabetes (74,75). In this analysis of the full SWAN 
cohort, the prevalence of PN is similar to that observed eight years earlier at the Michigan 
SWAN site (5). Notably, this current analysis found a high prevalence (22.8%) of PN in 
women without diabetes, suggesting that increased clinical focus on the problem of PN in 
the general population of women is need, especially given evidence that PN is a significant 
determinant of multiple dimensions of disability (76,77). Furthermore, the increased 
prevalence of PN may be due to the method of measurement of PN. Many previous studies 
have used only monofilament testing to characterize PN, which in the present analysis would 
lead to a reduction in the number of PN cases by approximately 50% (4,23). Early work 
describing the use of two instruments (in this case the MNSI and monofilament testing) 
proved to provide a more sensitive and reliable measure of neuropathies among individuals 
with diabetes than one instrument alone as each may be capturing differing severities of PN 
(31).
There are several limitations with this study. First, PN was not measured at baseline or at 
other early study visits, so we could not separate existing PN from neuropathy that 
developed over the course of the study period. This may have introduced issues of 
temporality into our study, however increasing age contributes to neuropathy development, 
and measures were chosen to establish temporality between perceived discrimination 
(baseline) and BMI (the mediator, measured concurrently with PN). Perceived 
discrimination was assessed at baseline, but these experiences can accumulate over time, and 
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can be a regular and pervasive experience throughout the life course. Perceived 
discrimination has been shown to be stable over time in the SWAN cohort (19). Because 68 
women (10.6%) reported that they experienced discrimination mainly because of their 
physical appearance, we ran a sensitivity analysis with these women removed in order to 
reduce the possibility of reverse causation – i.e. that for some, higher BMI (physical 
appearance) could be leading to discrimination. The estimates of the association of 
perceived discrimination with PN did not change significantly in this sensitivity analysis 
(unadjusted OR = 1.39, 95% CI: 1.10, 1.75; adjusted model OR = 1.18, 95% CI: 0.90, 1.53). 
Despite these limitations, this analysis has many strengths overall. Using two standardized 
measures of PN gives more robust estimates of disease (19,40). This large, community-
based cohort design allowed us to investigate PN among women with and without diabetes, 
as well as women of diverse racial/ethnic backgrounds.
CONCLUSIONS
Nearly all previous PN research has focused primarily on populations with diabetes, 
however our analysis found that almost one-fourth of women without diabetes have PN. 
More research is needed to determine the contributing factors to non-diabetic PN. Clinicians 
should consider this high prevalence when diagnosing and treating both patients with and 
without diabetes for neuropathy. This study also found that midlife perceived discrimination 
was a significant predictor of PN and that this association was significantly mediated by 
BMI. Our findings re-affirm the impact of financial strain, BMI and diabetes as significant 
correlates of PN measured by symptom questionnaire and monofilament testing and show 
the impact of discrimination as an important risk factor for PN in women with and without 
diabetes.
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Glossary
BMI Body Mass Index
CA California
CI Confidence Interval
dL deciliter
IL Illinois
Kg Kilogram
M Meter
MA Massachusetts
Mg Milligrams
MI Michigan
MNSI Michigan Neuropathy Screening Instrument
NJ New Jersey
OR Odds Ratio
PA Pennsylvania
SD Standard Deviation
SWAN Study of Women’s Health Across the Nation
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Table 1.
Characteristics of All Participants, Participants with Diabetes and Participants with Peripheral Neuropathy, 
Study of Women’s Health Across the Nation, 1996–2016
Total
(n= 1718)
Diabetes
(n = 320) P-valuea
Peripheral Neuropathy
(n = 449) P-valueb
Visit 15 age in years, mean (SD) 65.6 (2.7) 65.6 (2.7) 0.88 65.6 (2.7) 0.73
Race / ethnicity, N (%) <0.01 <0.01
 African-American 454 (26.4) 134 (41.9) 141 (31.4)
 Chinese 174 (10.1) 26 (8.1) 40 (8.9)
 Hispanic 97 (5.7) 35 (10.9) 31 (6.9)
 Japanese 171 (10.0) 18 (5.6) 16 (3.6)
 White 822 (47.9) 107 (33.4) 221 (49.2)
Financial strain, N (%) <0.01 <0.01
 Very or somewhat hard 570 (33.9) 144 (45.1) 185 (42.0)
 Not hard 1111 (66.1) 175 (54.9) 256 (58.0)
Smoking, N (%) <0.01 <0.01
 Current 111 (6.5) 49 (12.3) 43 (9.7)
 Former or never 1590 (93.5) 277 (87.7) 401 (90.3)
BMI in kg/m2, mean (SD) 29.2 (7.1) 33.1 (7.4) <0.01 31.4 (7.6) <0.01
Perceived discrimination, mean (SD) 1.7 (0.5) 1.8 (0.5) <0.01 1.8 (0.5) <0.01
Abbreviations: SD, standard deviation; BMI, body mass index
a
Two-sided P-value comparing women with and without diabetes; chi-square test for categorical variables; t-test for continuous variables
b
Two-sided P-value comparing women with and without peripheral neuropathy; chi-square test for categorical variables; t-test for continuous 
variables
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Table 2.
Prevalence of Peripheral Neuropathy by Diabetes Status, Study of Women’s Health Across the Nation, 1996–
2016
Total
(n = 1718)
With Diabetes (n = 320) Without Diabetes
(n = 1398)
n % n % n % P-valuea
Peripheral Neuropathy 449 26.1 131 40.9 318 22.8 <0.01
MNSI, ≥ 4 symptoms 282 16.4 106 33.1 176 12.6 <0.01
Monofilament insensitivity, < 3 correct responses 232 13.7 58 18.8 174 12.5 <0.01
Both MNSI and Monofilament 65 3.8 33 10.7 32 2.3 <0.01
Abbreviations: MNSI, Michigan Neuropathy Screening Instrument
a
Two-sided chi-square test comparing women with and without diabetes
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